SCHEMBL9726813

SCHEMBL9726813

CC(=O)c1ccc([Si](C)(C)C)cc1C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.42
ACHE P22303 1/20 0.40
HPGD P15428 2/20 0.36
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 1/20 0.35
MAPK1 P28482 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 3/20 0.34
KMT2A Q03164 1/20 0.34
HTT P42858 2/20 0.33
TSHR P16473 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
CA9 Q16790 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9726921 0.84 SMN1; SMN2 (0.42) SMN1; SMN2ACHEALDH1A1NPC1RAB9A
SCHEMBL9730784 0.84 RXRB (0.47) ACHEHPGDALDH1A1KDM4ERXRA
SCHEMBL9716881 0.82 ACHE (0.39) SMN1; SMN2ACHEHPGDALDH1A1NPC1
SCHEMBL9716901 0.81 ACHE (0.38) ACHEHPGDALDH1A1NPC1RAB9A
SCHEMBL8345539 0.80 ALDH1A1 (0.52) SMN1; SMN2ACHEHPGDALDH1A1CYP3A4
SCHEMBL9726808 0.78 ACHE (0.39) SMN1; SMN2ACHEHPGDALDH1A1CYP3A4
SCHEMBL8345919 0.76 HTT (0.41) SMN1; SMN2ACHEHPGDALDH1A1CYP3A4
SCHEMBL9726917 0.74 ACHE (0.39) SMN1; SMN2ACHEHPGDALDH1A1CYP3A4
SCHEMBL5012568 0.74 ACHE (0.33) ACHEHPGDNPC1RAB9A
SCHEMBL29381894 0.74 KMT2A (0.51) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5081271-A Differentiation-inducing agent for neoplastic cells; therapeutic agent for psoriasis or immune and inflammatory diseases TAIHO PHARMACEUTICAL CO., LTD. (JP) 1992-01-14 US disclosed